sec filing
RN
NASDAQ · RNAZ
TransCode Therapeutics, Inc.
Healthcare · Biotechnology
$1.78
Down-$0.02 (-1.12%)
Updated Oct 8, 2026, 12:32 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.55M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $1.52 – $20.99
- Volume
- 47.34K
- Avg. volume
- 142.25K
Price performance · RNAZ
RNAZ price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
RNAZ closed at $1.78 after 20 trading sessions, up 0.00% for the selected period.
- Last close
- $1.78
- Period change
- +0.00%
- Period low
- $1.55
- Period high
- $1.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $1.77 | $1.8154 | $1.71 | $1.78 | 47.34K |
| Oct 5, 2026 | $1.65 | $1.87 | $1.57 | $1.76 | 65.73K |
| Oct 2, 2026 | $1.58 | $1.66 | $1.545 | $1.57 | 15.5K |
| Oct 1, 2026 | $1.6733 | $1.74 | $1.52 | $1.545 | 16.71K |
| Sep 30, 2026 | $1.7482 | $1.7482 | $1.64 | $1.68 | 6.73K |
| Sep 29, 2026 | $1.73 | $1.81 | $1.60 | $1.63 | 11.01K |
| Sep 28, 2026 | $1.71 | $1.79 | $1.63 | $1.71 | 40.68K |
| Sep 25, 2026 | $1.60 | $1.70 | $1.60 | $1.69 | 14.76K |
| Sep 24, 2026 | $1.62 | $1.74 | $1.62 | $1.65 | 28.66K |
| Sep 23, 2026 | $1.835 | $2.39 | $1.6214 | $1.68 | 425.72K |
| Sep 22, 2026 | $1.87 | $1.9109 | $1.7066 | $1.77 | 59.51K |
| Sep 21, 2026 | $1.67 | $1.9699 | $1.67 | $1.76 | 66.2K |
| Sep 18, 2026 | $2.00 | $2.00 | $1.65 | $1.65 | 30.9K |
| Sep 17, 2026 | $1.70 | $1.72 | $1.63 | $1.72 | 58.15K |
| Sep 16, 2026 | $1.66 | $1.71 | $1.5785 | $1.68 | 18.7K |
| Sep 15, 2026 | $1.65 | $1.6999 | $1.60 | $1.60 | 18.52K |
| Sep 14, 2026 | $1.65 | $1.72 | $1.65 | $1.65 | 20.66K |
| Sep 11, 2026 | $1.68 | $1.74 | $1.6265 | $1.69 | 11.45K |
| Sep 10, 2026 | $1.72 | $1.83 | $1.69 | $1.69 | 26.09K |
| Sep 9, 2026 | $1.86 | $1.95 | $1.75 | $1.78 | 30.94K |
Latest RNAZ news
The latest Smart Investors Daily articles mentioning RNAZ.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

